Recursion Pharmaceuticals Inc.
RXRX | NASDAQ
$3.97
+$0.14 (+3.66%)
At close: Sep 21, 2026, 4:00 PM ET
$3.95
-$0.02 (-0.50%)
Pre-market:
Sep 22, 2026, 6:25 AM ET
Institutional Ownership
Net InflowTotal Institutions
351
Total Ownership
63.51%
Capital Flow
+$294.28M
Shares Change
+11.87M
Ownership Distribution
Institutions (63.51%)
Others (36.49%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
61
Increased Positions
193
Reduced Positions
84
Closed Positions
60
New (61)
Increased (193)
Reduced (84)
Closed (60)
Options Sentiment & Activity
bullishPut/Call Ratio
0.642
Call Flow
4,595,352
Put Flow
2,948,200
Calls (61%)
Puts (39%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Bridgewater Associates LP | < 0.01% 0.00% | < 0.01% | 37.67K | 144.26K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.16% -6.06% | < 0.01% -13.78% | 43.19M +11.13% | 132.6M -16.59% | |
| Ark Investment Management LLC | 7.60% -8.90% | 0.96% -5.23% | 40.21M +7.76% | 123.45M -19.11% | |
| State Street Corp | 5.38% -4.93% | < 0.01% -13.12% | 28.49M +12.46% | 87.47M -15.59% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove RXRX